Podcast: Type 2 Inflammation: Health Disparities & Impact on Minority Populations
Moderator:
Illinois State Senator Mattie Hunter, Midwestern Regional Director, WIG Board of Directors
Featuring:
Dr. Debra Sierka, Senior Medical Director, Dermatology Dupilumab, NA Immunology, Sanofi Genzyme
Dr. Gary Puckrein, PhD., President, National Minority Quality Forum (NMQF)
Kenny Mendez, CEO and President, the Asthma and Allergy Foundation of America (AAFA)
Listen Now! (Podcast link coming soon)
Type 2 Inflammation Resources:
- Dr. Gary Puckerein, PhD, Biography
- Sources for Information Mentioned in the 2021 Type 2 Inflammaton Podcast Recording
- Illinos State Senator Mattie Hunter; Health Care & Human Services Pillar
- Illinois General Assembly - Bill Status for House Bill 0158
- Illinois General Assembly - Bill Status for Senate Bill 2439
- National Minority Quality Forum Annual Report 2020
- Asthma Disparities in America
- 69 Strategies to Address Disparities in Asthma
- This report lists the 100 largest cities that are most challenging to live in if you have allergies.
- A Message from AAFA'S CEO on Seasonal Allergies on The Weather Channel's Local Now
- The report lists the 100 largest cities that are most challenging to live in if you have asthma
- AAFA ranks the states that have the best public policies for people with asthma, allergies, anaphylaxis and related allergic diseases in the U.S. elementary, middle and high schools.
- My Life with Asthma and Food Allergies
Podcast: It Take 2: Type 2 Inflammation (2020)
Moderator:
California State Senator Melissa Hurtado
Featuring:
Carole Huntsman, Head, Sanofi Genzyme North America and US Country Lead
Dr. Mandeep Kaur, Vice President, Head, North America Medical for Dupixent at Sanofi Genzyme
Dr. Tyra Bryant-Stephens, Director and Founder, The Community Asthma Prevention Program, Clinical Professor of Pediatrics, The Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania
People of all ages, genders, and backgrounds are connected by similar challenges because of one lesser known chronic condition known as Type 2 Inflammation. Recent scientific developments have shown that this overactive immune system response, underlies different atopic, allergic and inflammatory diseases. What exactly does that mean and how does it affect our families and communities? On this episode of the Women In Government Podcast, our panel discusses how the Type 2 Inflammation connection can help patients work with their doctors to gain control of their chronic disease.
As for policymakers and industry leaders, these chronic conditions impact communities of color and those in underserved communities. Now’s the time to get to work and support measures to address Type 2 Inflammation.
Webinar: It Takes Two - Type 2 Inflammation
Type 2 Inflammation Resources: